Weight Loss Supplement
Relacore
These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.
Most Reported Reactions
Top 10 reactions from 51 reports. One report may include multiple reactions — reaction totals may exceed the report count.
Reported Outcomes
Outcome categories as recorded in FDA reports. One report may include multiple outcomes.
| Outcome | Reports |
|---|---|
| Other Outcome | 25 |
| Other Serious or Important Medical Event | 13 |
| Hospitalization | 11 |
| Visited a Health Care Provider | 9 |
| Life Threatening | 5 |
| Disability | 3 |
| Visited Emergency Room | 3 |
| Required Intervention | 3 |
Who Reported
Reporter demographics where available. Many reports do not include age or gender data.
Age
39 reports had age data; 12 unknown.
Gender
Reports by Year
Annual report counts from 2004–2019. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.
'04
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Hover bars for exact counts.
Context about this data: Reports concentrated in 2006 (35% of total, spanning 2004–2019), suggesting a reporting event during that period rather than evenly distributed consumer use.
Data Source
This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.
View openFDA CAERS data ↗ · About our methodology · How to read this data